ORGO Organogenesis Holdings Inc
Price (delayed)
$5.3
Market cap
$672.19M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.01
Enterprise value
$579.35M
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's
Highlights
ORGO's debt has dropped by 64% year-on-year and by 59% since the previous quarter
The quick ratio has grown by 38% year-on-year and by 25% since the previous quarter
The EPS has dropped by 125% year-on-year but it has surged by 83% since the previous quarter
The net income has soared by 112% from the previous quarter but it has plunged by 83% YoY
ORGO's equity is down by 6% YoY and by 6% QoQ
Key stats
What are the main financial stats of ORGO
Market
Valuations
Earnings
Shares outstanding
126.83M
Market cap
$672.19M
Enterprise value
$579.35M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.67
Price to sales (P/S)
1.45
EV/EBIT
N/A
EV/EBITDA
24.03
EV/Sales
1.2
Revenue
$482.04M
Gross profit
$366.3M
Operating income
-$1.26M
Net income
$861,000
EBIT
-$1.26M
EBITDA
$24.11M
Free cash flow
$4.18M
Per share
Balance sheet
Liquidity
EPS
-$0.01
EPS diluted
-$0.01
Free cash flow per share
$0.03
Book value per share
$1.98
Revenue per share
$3.66
TBVPS
$3.47
Total assets
$497.89M
Total liabilities
$112.57M
Debt
$43.31M
Equity
$262.9M
Working capital
$208.46M
Debt to equity
0.16
Current ratio
3.69
Quick ratio
3.18
Net debt/EBITDA
-3.85
Margins
Efficiency
Dividend
EBITDA margin
5%
Gross margin
76%
Net margin
0.2%
Operating margin
-0.3%
Return on assets
-0.2%
Return on equity
-0.3%
Return on invested capital
-0.4%
Return on capital employed
-0.3%
Return on sales
-0.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ORGO stock price
How has the Organogenesis Holdings stock price performed over time
Intraday
3.31%
1 week
5.16%
1 month
46.81%
1 year
77.85%
YTD
65.63%
QTD
65.63%
Financial performance
How have Organogenesis Holdings's revenue and profit performed over time
Revenue
$482.04M
Gross profit
$366.3M
Operating income
-$1.26M
Net income
$861,000
Gross margin
76%
Net margin
0.2%
ORGO's net margin has soared by 113% since the previous quarter but it has dropped by 82% year-on-year
The net income has soared by 112% from the previous quarter but it has plunged by 83% YoY
Organogenesis Holdings's operating income has plunged by 110% YoY but it has soared by 90% from the previous quarter
Organogenesis Holdings's operating margin has shrunk by 110% YoY but it has surged by 89% QoQ
Growth
What is Organogenesis Holdings's growth rate over time
Valuation
What is Organogenesis Holdings stock price valuation
P/E
N/A
P/B
2.67
P/S
1.45
EV/EBIT
N/A
EV/EBITDA
24.03
EV/Sales
1.2
The EPS has dropped by 125% year-on-year but it has surged by 83% since the previous quarter
The P/B is 91% above the last 4 quarters average of 1.4 but 43% below the 5-year quarterly average of 4.7
ORGO's equity is down by 6% YoY and by 6% QoQ
ORGO's P/S is 81% above its last 4 quarters average of 0.8 but 19% below its 5-year quarterly average of 1.8
The company's revenue rose by 11% YoY and by 6% QoQ
Efficiency
How efficient is Organogenesis Holdings business performance
The ROA has plunged by 118% YoY but it has soared by 88% from the previous quarter
Organogenesis Holdings's return on equity has shrunk by 117% YoY but it has surged by 89% QoQ
The return on invested capital has dropped by 111% year-on-year but it has surged by 89% since the previous quarter
The return on sales has dropped by 110% year-on-year but it has surged by 89% since the previous quarter
Dividends
What is ORGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ORGO.
Financial health
How did Organogenesis Holdings financials performed over time
The quick ratio has grown by 38% year-on-year and by 25% since the previous quarter
Organogenesis Holdings's total liabilities has decreased by 38% YoY and by 33% QoQ
ORGO's debt is 84% smaller than its equity
ORGO's debt has dropped by 64% year-on-year and by 59% since the previous quarter
The debt to equity has dropped by 63% year-on-year and by 58% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.